Company Overview

Development Stage

About the Company

覆盖医药行业全产品,欢迎有志之士

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (28 open positions)

Manage
Note: How fast is hiring at 阿斯利康医药(北京)有限公司 growing? 2026: 41 openings (down 5%), 2025: 43 openings (up 95%), 2024: 22 openings (up 340%), 2023: 5 openings (up 67%), 2022: 3 openings (up 200%), 2021: 1 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 阿斯利康医药(北京)有限公司? Based on an analysis of 's job postings over the past year, "医疗卫生/美容保健类" demand: 27%, "计算机/网络/技术类": 4.8%. For reference only.

— What Are the Salaries Like? (63 records)

Manage
salary range: 3K - 30K, 65.1% of roles pay ¥8-15K
Note: salary statistics are based on 63 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 阿斯利康医药(北京)有限公司?65.1% of positions earn 8-15K, Fresh graduate salary: ¥3.8K。销售类 average salary ¥11.8K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 阿斯利康医药(北京)有限公司? We provide: 医药代表,销售,实习生,推广,药学,信息,医学代表,学术专员,临床. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 销售类
    90.5% of total 90.5%
  • 医疗卫生/美容保健类
    27% of total 27%
  • 在校学生类
    11.1% of total 11.1%
  • 市场/公关/媒介类
    9.5% of total 9.5%

Education

  • 本科
    57.1% of total 57.1%
  • 大专
    38.1% of total 38.1%
  • 不限
    4.8% of total 4.8%

Experience

  • 1-3年
    47.6% of total 47.6%
  • 不限
    46% of total 46%
  • 应届生
    3.2% of total 3.2%
  • 3-5年
    3.2% of total 3.2%
View Detailed Analysis

What does 阿斯利康医药(北京)有限公司 require? Who is 阿斯利康医药(北京)有限公司 hiring? recruitment: 销售类占比最多占90.5%,其次是医疗卫生/美容保健类占27%. What education can get in at ? 本科占比最多占57.1%,其次是大专占38.1%. Work experience required at ? 1-3年占比最多占47.6%,其次是不限占46%. Where are the job locations at ? 北京占比最多占79.4%,其次是成都占3.2%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 3,000万(元)
Legal Representative: 黄彬
Date Established:
Credit Code: 91110105MA01803N93
Registered Address: 北京市北京经济技术开发区科谷一街8号院4号楼1层

Partners & Suppliers

阿斯利康通过国药控股分销药品,国药控股为其在中国的主要经销商之一。 Source
合作客户 医药流通
阿斯利康与百度健康合作推出慢病管理服务。 Source
合作客户 数字化医疗
博腾股份与阿斯利康在原料药及关键中间体方面有合作。 Source
供应商 原料药
一心堂与阿斯利康在患者教育项目上有合作。 Source
合作客户 零售药店
华润医药为阿斯利康提供药品配送服务,覆盖全国多家医院。 Source
合作客户 医药流通

People who follow this company also follow

Competitors (Similar Companies)

“Pioneering innovation, benefiting patients”
“Global integrated biopharmaceutical enterprise”
抗感染药物 中枢神经药 医药 药物研发
“Although the processing is complicated, we dare not save labor; althou”
研究院/研究所 生物信息 生物信息学 蛋白质组学
药物研发 生物医药 仿制药 化学合成药
生命科学研究 干细胞 基因工程 抗衰老
ro纯水机 售水机 生产 研发
“Advancing medical science to help people live healthier lives”
医疗科技 神经介入 介入治疗 脑卒中
医药 药物研发 生物医药 新药研发
“Continuously innovating to bring patients medicines that significantly”
医药 生物制品 生物医药 生物制药
诊断试剂 生物医药 疫苗 生物科技/生物工程
“Focused on three major fields: healthcare, life science, and electroni”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates